lncRNA ANRIL knockdown in tumor cells inhibits proliferation, induces apoptosis and increases cisplatin cytotoxicity in tumor cells via impairment of the drug transporters MRP1 and ABCC2, which can be restored by treatment with human MK in a caspase-3/BCL-2-dependent manner. Here, BCL2 is linked to neoplasm.